loader image
Tuesday, October 14, 2025
81.4 F
McAllen
- Advertisement -

A Shortage with a Silver Lining: A Chance to Reduce Unneeded Blood Tests

Translate to Spanish or other 102 languages!

The shortage of “blue top” blood test tubes gave researchers a chance to see if alerting doctors at the moment they’re placing an order could encourage them to seek a test only when results will immediately affect care. Image for illustration purposes
The shortage of “blue top” blood test tubes gave researchers a chance to see if alerting doctors at the moment they’re placing an order could encourage them to seek a test only when results will immediately affect care. Image for illustration purposes

Mega Doctor News

- Advertisement -

By Michigan Medicine – University of Michigan 

Newswise — A pandemic-related shortage of a mundane item – tubes to collect blood samples from patients — has caused headaches for health systems worldwide.

But it also has a silver lining: A lesson in how to reduce unneeded medical tests, whether or not there’s a shortage, according to a new study.

- Advertisement -

The shortage of “blue top” blood test tubes gave researchers a chance to see if alerting doctors at the moment they’re placing an order could encourage them to seek a test only when results will immediately affect care.

In the new study, published in JAMA Internal Medicine, an alert led to a nearly immediate 29% drop in orders for one common test. The reduced level persisted for months.

“This shows that small interventions can make a big difference, and suggests the potential for other types of low-value care to benefit from a similar intervention,” says lead author Madison Breeden, M.D., a fellow in infectious diseases at U-M Health who conducted the study during her year as chief resident of Quality and Patient Safety. She’s already exploring if the approach might reduce unnecessary prescribing of antibiotics.

Breeden and her colleagues describe what happened in spring 2021 when University of Michigan Health supply chain and pathology experts began worrying about a potential shortage of “blue top” tubes. The pandemic had created very high demand for the chemical the tubes contain: sodium citrate, which stabilizes blood samples until a laboratory team can analyze three blood clotting-related properties, called PT, INR and PTT.

- Advertisement -

After emailing all providers, U-M Health added a “best practices alert” to doctors’ test-ordering electronic system. They could still order PT/INR/PTT tests, but were asked for “thoughtful restraint in reflexive ordering.”

The alert began popping up a month before the U.S. Food and Drug Administration issued an official shortage notice and the issue got widespread attention. The shortage continues today and has grown to other types of tests.

The researchers looked at what happened for six months after the alert began appearing at U-M Health, and compared it with data from six months before.

“There are very important reasons to order this test in some patients, for instance before an operation or when managing certain conditions and treatments,” Breeden explains. “But it may also be part of a standard order set that’s put in during an emergency department visit and continues to be ordered repeatedly after the patient is admitted to the hospital, even though the results won’t change their care.” For such patients, a one-time test might be indicated, but not repeated testing.

Busy doctors entering orders for tests don’t tend to think about the supplies and people power needed to carry out those tests, Breeden notes. In the face of a shortage, or of strong evidence that a test is often over-ordered, an alert could help prioritize the tests for those who need them most.

Canadian experts have actually flagged PT/INR/PTT tests as a target for reducing unnecessary care, through the Choosing Wisely program. So has the American Society for Clinical Laboratory Science, a medical professional group.

In addition to Breeden, the study’s authors are Steven J. Bernstein, MD, MPH, Rodney A. Hayward, MD, and A. Mark Fendrick, M.D.

Paper cited: 

Evaluation of a Best Practice Advisory on Ordering Prothrombin Time, International Normalized Ratio, and Partial Thromboplastin Time Tests, JAMA Internal Medicine, doi:10.1001/jamainternmed.2022.2609, https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2794392

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Promotes Early Detection with $99 Mammogram Special

 In recognition of Breast Cancer Awareness Month, DHR Health is offering a $99 mammogram screening special from October 1–31, 2025, as part of its ongoing commitment to women’s health and early detection.

Study Shows Nearly Half of People with Diabetes Don’t Know They Have it 

“By the time people are diagnosed with diabetes, they have progressed to the point where they've already started feeling thirsty or peeing all the time. And so, because it's not one of those conditions that cause pain until you have progressed so far, I think this is a very common thing that we have noticed as practitioners,” said Peminda Cabandugama, MD, endocrinologist at Cleveland Clinic.

STC Student Rises from Life-Changing Car Crash to Pursue Pharmacy Dream

Mega Doctor News By Selene Rodriguez For 10 years, South Texas College student...

CDC Report Finds Sharp Rise in Dangerous Drug-Resistant Bacteria

A new report from the Centers for Disease Control and Prevention (CDC), published in the Annals of Internal Medicine, highlights a dramatic increase in a dangerous type of drug-resistant bacteria called NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE). 
- Advertisement -
×